Herbalife Ltd. (NYSE:HLF) today provided a preview of anticipated
results for its fourth quarter and fiscal year ended December 31, 2013.
The company reported preliminary, unaudited results that include the
following:
-
Volume Points for full year and fourth quarter 2013 are expected to
increase approximately 13.1% and 12.7%, respectively, compared to the
prior year periods.
-
Net sales for full year and fourth quarter 2013 are expected to
increase approximately 18.5% and 19.8%, respectively, compared to the
prior year periods.
-
Fourth quarter adjusted1 diluted EPS is expected to be in a
range of $1.26 to $1.30. Fourth quarter as reported diluted EPS is
expected to be in a range of $1.13 to $1.17, as compared to prior year
fourth quarter as reported diluted EPS of $1.00. There were no
non-GAAP adjustments reported against the company’s 2012 fourth
quarter U.S. GAAP results.
-
Full year adjusted1 diluted EPS is expected to be in a
range of $5.35 to $5.39. Full year as reported diluted EPS is expected
to be in a range of $4.89 to $4.93, as compared to prior full year as
reported diluted EPS of $3.94. There were no non-GAAP adjustments
reported against the company’s 2012 full year U.S. GAAP results.
Herbalife also announced the following:
-
The company expects to report full year financial results on February
18, 2014.
-
The company’s 2014 full year Volume Point growth and adjusted2
EPS guidance of 6.5% to 8.5% and $5.45 to $5.65, respectively, remains
unchanged, despite approximately $0.10 adverse foreign currency
exchange rate impact compared to prior guidance.
-
First quarter 2014 adjusted2 EPS is expected to be in a
range of $1.24 to $1.28 despite an approximately $0.20 adverse foreign
currency exchange rate impact compared to the prior year’s results.
-
The company's board of directors has increased the existing share
repurchase authorization to an available balance of $1.5 billion.3
The company's former share repurchase authorization of $1 billion had
an available balance of $653 million.
-
The company expects to begin repurchasing shares of Herbalife common
stock.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells
weight-management, nutrition, and personal care products intended to
support a healthy lifestyle. Herbalife products are sold in over 90
countries through and to a network of independent distributors. The
Company supports the Herbalife Family Foundation and its Casa Herbalife
program to help bring good nutrition to children. Herbalife's website
contains a significant amount of financial and other information
about Herbalife for investors at http://ir.Herbalife.com.
The company encourages investors to visit its website from time to time,
as information is updated and new information is posted.
1 Fourth quarter and full year 2013 adjusted diluted EPS
excludes the impact, net of taxes, of the February 2013 devaluation of
the Venezuelan bolivar; expenses (primarily for legal and advisory
services) relating to the company’s response to information put into the
marketplace by a short seller, which the company believes to be
inaccurate and misleading; and expenses incurred in connection with the
re-audit of 2010-2012 financial statements resulting from KPMG LLP’s
resignation. See Schedule A – “Reconciliation of Non-GAAP Financial
Measures” for more detail.
2 Forward guidance excludes the impact of expenses (primarily
for legal and advisory services) relating to the company’s response to
information put into the marketplace by a short seller, which
information the company believes to be inaccurate and misleading and the
impact of the recently announced financing transaction and any
subsequent share repurchase activity. Forward guidance is based on the
average daily exchange rates of the first two weeks of January. Included
in the guidance is the use of the GAAP rate for Venezuela of 6.3 to 1
for January results and 10 to 1 for the balance of the year and excludes
the potential impact of future devaluation of the Venezuelan bolivar and
any future repatriation of existing cash balances in Venezuela.
3 Our financial statement filings with the Securities and
Exchange Commission present our consolidated results. Herbalife Ltd. is
incorporated in the Cayman Islands. Under Cayman Islands law, our
ability to pay dividends and repurchase shares of our common stock is
determined by the amount of distributable reserves evident from the
balance sheet of our parent company. Our current distributable reserves
exceed our current share repurchase authorization.
FORWARD-LOOKING STATEMENTS
Although we believe that the expectations reflected in any of our
forward-looking statements are reasonable, actual results could differ
materially from those projected or assumed in any of our forward-looking
statements. Our future financial condition and results of operations, as
well as any forward-looking statements, are subject to change and to
inherent risks and uncertainties, such as those disclosed or
incorporated by reference in our filings with the Securities and
Exchange Commission. Important factors that could cause our actual
results, performance and achievements, or industry results to differ
materially from estimates or projections contained in our
forward-looking statements include, among others, the following:
-
potential differences between the final, audited results that have not
been determined as of the date of this release and the preliminary
unaudited results disclosed in this release;
-
any collateral impact resulting from the ongoing worldwide financial
environment, including the availability of liquidity to us, our
customers and our suppliers or the willingness of our customers to
purchase products in a difficult economic environment;
-
our relationship with, and our ability to influence the actions of,
our distributors;
-
improper action by our employees or distributors in violation of
applicable law;
-
adverse publicity associated with our products or network marketing
organization, including our ability to comfort the marketplace,
regulators and other third parties regarding our compliance with
applicable laws;
-
changing consumer preferences and demands;
-
our reliance upon, or the loss or departure of any member of, our
senior management team which could negatively impact our distributor
relations and operating results;
-
the competitive nature of our business;
-
regulatory matters governing our products, including potential
governmental or regulatory actions concerning the safety or efficacy
of our products and network marketing program, including the direct
selling market in which we operate;
-
legal challenges to our network marketing program;
-
risks associated with operating internationally and the effect of
economic factors, including foreign exchange, inflation, disruptions
or conflicts with our third-party importers, pricing and currency
devaluation risks, especially in countries such as Venezuela;
-
uncertainties relating to the application of transfer pricing, duties,
value added taxes, and other tax regulations, and changes thereto;
-
uncertainties relating to interpretation and enforcement of
legislation in China governing direct selling;
-
uncertainties relating to the interpretation, enforcement or amendment
of legislation in India governing direct selling;
-
our inability to obtain the necessary licenses to expand our direct
selling business in China;
-
adverse changes in the Chinese economy, Chinese legal system or
Chinese governmental policies;
-
our dependence on increased penetration of existing markets;
-
contractual limitations on our ability to expand our business;
-
our reliance on our information technology infrastructure and outside
manufacturers;
-
the sufficiency of trademarks and other intellectual property rights;
-
product concentration;
-
changes in tax laws, treaties or regulations, or their interpretation;
-
taxation relating to our distributors;
-
product liability claims;
-
whether we will purchase any of our shares in the open markets or
otherwise; and
-
share price volatility related to, among other things, speculative
trading and certain traders shorting our common shares.
We do not undertake any obligation to update or release any revisions
to any forward-looking statement or to report any events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events, except as required by law.
SUPPLEMENTAL INFORMATION
SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited
and unreviewed)
In addition to its anticipated results, the company has included in
this release "adjusted diluted EPS" (earnings per share), a measure the
Securities and Exchange Commission defines as a "non-GAAP financial
measure." Management believes that this non-GAAP financial measure, when
read in conjunction with the company's as-reported expected results, can
provide useful supplemental information for investors when comparing
period-to-period results. However, non-GAAP financial measures such as
adjusted diluted EPS should not be considered a substitute for, nor
superior to, financial results and measures determined or calculated in
accordance with GAAP.
The following is a reconciliation of as-reported preliminary diluted
EPS, presented and reported in accordance with U.S. generally accepted
accounting principles, to adjusted preliminary diluted EPS:
|
|
|
|
|
|
|
|
|
($ in thousands except for earnings per share)
|
|
|
|
Three Months Ended
|
|
|
|
Twelve Months Ended
|
|
|
|
|
12/31/13
|
|
|
|
12/31/13
|
|
|
|
12/31/12
|
|
|
|
12/31/13
|
|
|
|
12/31/13
|
|
|
|
12/31/12
|
|
|
|
|
Low
|
|
|
|
High
|
|
|
|
|
|
|
|
Low
|
|
|
|
High
|
|
|
|
|
|
|
|
|
(Preliminary)
|
|
|
|
|
|
|
|
(Preliminary)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share, as reported
|
|
|
|
$
|
1.13
|
|
|
|
$
|
1.17
|
|
|
|
$
|
1.00
|
|
|
|
$
|
4.89
|
|
|
|
$
|
4.93
|
|
|
|
$
|
3.94
|
Venezuela devaluation impact (net of ($1,442) and $5,354 tax
benefit for the three and twelve months ended December 31, 2013,
respectively) (1)(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
|
0.01
|
|
|
|
|
-
|
|
|
|
|
0.09
|
|
|
|
|
0.09
|
|
|
|
|
-
|
Expenses incurred responding to attacks on the Company's business
model (net of $1,455 and $4,696 tax benefit for the three and twelve
months ended December 31, 2013, respectively)(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.04
|
|
|
|
|
0.04
|
|
|
|
|
-
|
|
|
|
|
0.23
|
|
|
|
|
0.23
|
|
|
|
|
-
|
Expenses incurred for the re-audit of 2010 to 2012 financial
statements due to resignation of KPMG (net of $2,422 and $4,750 tax
benefit for the three and twelve months ended December 31, 2013)(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.07
|
|
|
|
|
0.07
|
|
|
|
|
-
|
|
|
|
|
0.14
|
|
|
|
|
0.14
|
|
|
|
|
-
|
Diluted earnings per share, as adjusted(3)
|
|
|
|
$
|
1.26
|
|
|
|
$
|
1.30
|
|
|
|
$
|
1.00
|
|
|
|
$
|
5.35
|
|
|
|
$
|
5.39
|
|
|
|
$
|
3.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
|
The income tax impact of the non-GAAP adjustments is based on items
affecting the company’s 2013 full year GAAP effective tax rate.
Adjustments to items unrelated to these non-GAAP adjustments have
had an effect on the income tax impact of the non-GAAP adjustments
in periods subsequent to the underlying non-GAAP adjustments.
|
(2)
|
|
|
The amount for the three months ended December 31, 2013 relates to
the change in tax benefit, as explained in note 1, for the Venezuela
devaluation that was recorded in the first quarter
|
(3)
|
|
|
Amounts may not total due to rounding.
|
|
|
|
|
Copyright Business Wire 2014